http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022238389-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8daf90d4ef47aa89af5ad9728142c54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5efad9054de77d4c58e5b0972dc46713
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-30
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C55-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C57-145
filingDate 2022-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c1cceb29b8e3168b4b4b5cb8105a608
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3caac5ce5060dfaccaa86844465ef9e1
publicationDate 2022-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2022238389-A2
titleOfInvention Novel forms of entinostat
abstract The present disclosure relates to various crystalline forms of entinostat and to processes for their preparation, particularly Form A of entinostat compound with maleic acid, Form A of entinostat compound with succinic acid, Form B of entinostat compound with succinic acid, and Form C of entinostat compound with succinic acid. The present disclosure also relates to pharmaceutical compositions comprising any of these forms of entinostat and to use of these forms in preparing a medicament or in treating a disease.
priorityDate 2021-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE45499-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7973166-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020270213-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017081278-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017216761-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414857470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539429
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22598030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7909
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411746874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538597
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474094
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3587356
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408978442
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412409465
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID723

Total number of triples: 46.